Check Cap Ltd (CHEK) Stock Analysis

Check Cap Ltd (CHEK) is a publicly traded company in the HEALTHCARE sector. It trades at $1.61. This page summarizes the public market data, fundamentals, and frequently asked questions for CHEK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $1.61

Market Sentiment

Check Cap Ltd currently has a Neutral sentiment score of 0.04.

About Check Cap Ltd

Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, that is transforming the landscape of colorectal cancer screening through its proprietary capsule-based imaging technology. The company is advancing a groundbreaking low-dose X-ray system that safely visualizes the colon's inner lining, facilitating the early detection of precancerous polyps and other abnormalities. As global health initiatives increasingly prioritize early detection and prevention strateg...

GNG Research Analysis

GNG Research scores Check Cap Ltd (CHEK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CHEK.

Frequently Asked Questions

Does CHEK pay dividends?

Check Cap Ltd (CHEK) does not currently pay a regular dividend.